RhumbLine Advisers’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-53,286
| Closed | -$2.48M | – | 4414 |
|
|
2023
Q2 | $2.48M | Sell |
53,286
-979
| -2% | -$45.5K | ﹤0.01% | 1788 |
|
|
2023
Q1 | $1.56M | Buy |
54,265
+2,675
| +5% | +$76.7K | ﹤0.01% | 1940 |
|
|
2022
Q4 | $1.61M | Buy |
51,590
+9,099
| +21% | +$284K | ﹤0.01% | 1900 |
|
|
2022
Q3 | $862K | Buy |
42,491
+2,469
| +6% | +$50.1K | ﹤0.01% | 2225 |
|
|
2022
Q2 | $621K | Buy |
40,022
+25,432
| +174% | +$395K | ﹤0.01% | 2377 |
|
|
2022
Q1 | $279K | Buy |
14,590
+4,258
| +41% | +$81.4K | ﹤0.01% | 2661 |
|
|
2021
Q4 | $262K | Buy |
+10,332
| New | +$262K | ﹤0.01% | 2753 |
|